Gypenosides ameliorate depression by modulating microglial state transition via the NLRP3/Caspase-1/ASC signaling pathway
Phytomedicine · 2026-07 · 156 · 158189
DOI: 10.1016/j.phymed.2026.158189 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026-07. Verfasst von Mei Guo und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Minzu University of China, Beijing 100081, China; Center on Translational Neuroscience, College of Life and Environmental Science…. Hauptthemen laut MEDLINE: Microglia, NLR Family, Pyrin Domain-Containing 3 Protein, Antidepressive Agents, Depression. Die Arbeit nennt 69 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Themen: Depression
Abstract (Originalsprache)
BACKGROUND Depression remains a major global health challenge. Microglial polarization imbalance and subsequent neuroinflammation are core pathological mechanisms. Given current treatment limitations, developing natural products with fewer side effects is a critical research priority. PURPOSE Gypenosides (Gyp) have demonstrated anxiolytic and antidepressant activity in acute depression models, whereas the antidepressant potential and mechanisms of its key constituent, gypenoside LVI (Gyp-LVI), remain unclear. This study aims to elucidate the antidepressant properties and molecular pathways of Gyp-LVI, and to further explore the efficacy and mechanisms of Gyp in more extensive models. METHODS This study utilized lipopolysaccharide (LPS)-induced BV-2 microglial cells and a chronic unpredictable mild stress (CUMS) mouse model to evaluate the antidepressant potential of Gyp/Gyp-LVI. Behavioral and molecular biological approaches were employed to investigate the underlying mechanisms of action. RESULTS In cellular experiments, Gyp/Gyp-LVI pretreatment inhibited BV-2 microglial proliferation induced by LPS, reduced the levels of inflammatory factors (TNF-α, IL-1β, IL-6), downregulated M1 markers (iNOS, CD86), and upregulated the M2 marker (Arg-1), while suppressing NLRP3 inflammasome activation. In mice, the 5-week CUMS model induced depression-like behaviors, elevated peripheral and central inflammation and oxidative stress, increased glial cell numbers in the hippocampus and PFC, shifted microglial polarization toward the M1 phenotype, and activated the NLRP3 pathway in the PFC. Gyp/Gyp-LVI intervention ameliorated these abnormalities and reversed the behaviors. Notably, Gyp and Gyp-LVI may differentially regulated microglial polarization: Gyp mainly inhibited M1 polarization, whereas Gyp-LVI both suppressed M1 and promoted a shift toward M2. CONCLUSIONS The antidepressant effects of Gyp/Gyp-LVI are associated with restoring inflammatory homeostasis, modulating oxidative stress, regulating glial cell polarization, and inhibiting the NLRP3/Caspase-1/ASC signaling pathway in the PFC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Minzu University of China, Beijing 100081, China; Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China; Pharmaceutical In…
- School of Pharmacy, Minzu University of China, Beijing 100081, China.
- Pharmaceutical Inspection Department, Ordos Inspection and Testing Center, Ordos City 017010, Inner Mongolia Autonomous Region, China.
- Food Inspection Department, Ordos Inspection and Testing Center, Ordos City 017010, Inner Mongolia Autonomous Region, China.
- Ordos Mongolian Hospital, Ordos City 017010, Inner Mongolia Autonomous Region, China.
- Center on Translational Neuroscience, College of Life and Environmental Sciences, Minzu University of China, Beijing 100081, China. Electronic address: yongcheng@muc.edu.cn.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Guo, M., Cui, C., Zheng, Z. J., Li, N., Yuan, H. S., Chen, Y. H., Ding, H., Zhang, Y., Cheng, Y., & Piao, X. L. (2026). Gypenosides ameliorate depression by modulating microglial state transition via the NLRP3/Caspase-1/ASC signaling pathway. Phytomedicine, 156, 158189. https://doi.org/10.1016/j.phymed.2026.158189
Vancouver
Guo M, Cui C, Zheng ZJ, Li N, Yuan HS, Chen YH, et al. Gypenosides ameliorate depression by modulating microglial state transition via the NLRP3/Caspase-1/ASC signaling pathway. Phytomedicine. 2026;156:158189. doi:10.1016/j.phymed.2026.158189
BibTeX
@article{Guo2026,
author = {Guo, Mei and Cui, Can and Zheng, Zhou-Juan and Li, Na and Yuan, Hai-Sheng and Chen, Yu-Han and Ding, Hua and Zhang, Ye and Cheng, Yong and Piao, Xiang-Lan},
title = {Gypenosides ameliorate depression by modulating microglial state transition via the NLRP3/Caspase-1/ASC signaling pathway},
journal = {Phytomedicine},
year = {2026},
volume = {156},
pages = {158189},
doi = {10.1016/j.phymed.2026.158189}
}
EUVIMED